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Edited by Vladimir SkulachevAbstract Mitochondrial aldehyde dehydrogenase (ALDH2) is
responsible for the metabolism of acetaldehyde and other toxic
lipid aldehydes. Despite many reports about the inhibition of
ALDH2 by toxic chemicals, it is unknown whether nitric oxide
(NO) can alter the ALDH2 activity in intact cells or in vivo ani-
mals. The aim of this study was to investigate the eﬀects of NO
on ALDH2 activity in H4IIE-C3 rat hepatoma cells. NO donors
such as S-nitrosoglutathione (GSNO), S-nitroso-N-acetylpeni-
cillamine, and 3-morpholinosydnonimine signiﬁcantly increased
the nitrite concentration while they inhibited the ALDH2 activ-
ity. Addition of GSH-ethylester (GSH-EE) completely blocked
the GSNO-mediated ALDH2 inhibition and increased nitrite
concentration. To directly demonstrate the NO-mediated S-nit-
rosylation and inactivation, ALDH2 was immunopuriﬁed from
control or GSNO-treated cells and subjected to immunoblot
analysis. The anti-nitrosocysteine antibody recognized the immu-
nopuriﬁed ALDH2 only from the GSNO-treated samples. All
these results indicate that S-nitrosylation of ALDH2 in intact
cells leads to reversible inhibition of ALDH2 activity.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Mitochondrial class 2 aldehyde dehydrogenase (EC 1.2.1.3;
ALDH2) is one of the key enzymes in the NAD+-dependent
oxidation of various aldehydes produced during intermediary
metabolisms. This enzyme exhibits a very low Km for acetalde-
hyde, and thus eﬃciently metabolizes acetaldehyde produced
during ethanol metabolism [1–3]. ALDH2 is also known to
metabolize toxic lipid aldehydes such as 4-hydroxy-2-nonenal
(HNE) and malondialdehyde (MDA), which are produced
after exposure to toxic chemicals [4,5]. ALDH2 is expressed
in many mammalian tissues [1–3]. Catalytically active ALDH2
is also present in certain cell lines such as H4IIE-C3 rat hepa-Abbreviations: ALDH2, mitochondrial aldehyde dehydrogenase; BSO,
l-buthionine-sulphoximine; DTT, dithiothreitol; GSH-EE, glutathione-
ethylester; GSNO, S-nitrosoglutathione; HNE, 4-hydroxy-2-nonenal;
MDA, malondialdehyde; NO, nitric oxide; S-NO-Cys, S-nitroso-cys-
teine; ROS/RNS, reactive oxygen/nitrogen species; SIN-1, 3-morpholi-
nosydnonimine Æ HCl; SNAP, S-nitroso-N-acetyl-D,L-penicillamine
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ALDH2 in the metabolism of potentially toxic aldehydes, inac-
tivation of ALDH2 by various chemicals [9–11] or under var-
ious disease states [12–15] is likely to cause marked
accumulation of toxic aldehydes, leading to increased suscepti-
bility towards irreversible damage.
Nitric oxide (NO) plays an important role in normal physio-
logical processes and pathological conditions, largely depend-
ing on the location, quantity, timing and duration of its
presence in the target cells [16,17]. In small quantities, NO
can be involved in normal signal transduction pathways, while
NO produced in large quantities can cause cellular damage [18]
by producing a potent oxidant peroxynitrite (ONOO) in the
presence of superoxide anion. Both peroxynitrite and NO do-
nors including S-nitrosoglutathione (GSNO) can modify cys-
teine (Cys) residues of target proteins, and thus negatively
aﬀect their functions in many cases [16,17]. Since Cys302 is crit-
ical for the catalytic activity of ALDH2 [19], ALDH2 may be
inhibited by increased reactive oxygen and nitrogen species
(ROS/RNS), possibly through modiﬁcation of the active site
Cys. In fact, earlier reports showed that the active site Cys in
the puriﬁed yeast ALDH2 enzyme can be modiﬁed in NO-inde-
pendent [20] and NO-dependent mechanisms [21]. In the latter
study, Cys residues in the puriﬁed yeast ALDH2 protein were
oxidized to intra-subunit disulﬁdes rather than S-nitrosylation
in the presence of NO donors, and this modiﬁcation was not re-
versed by the addition of glutathione (GSH) [21]. However, it is
still unknown whether ALDH2 in intact cells or in vivo animals
can be inhibited by NO and whether ALDH2 inhibition can be
reversed by reducing agents such as GSH. The aim of this study
was to investigate potential S-nitrosylation and the inactivation
of mammalian ALDH2 after cells were exposed to NO donors.
We also studied whether the inactivation of ALDH2 could be
reversed by a cell-permeable glutathione provider such as
GSH-ethylester (GSH-EE).2. Materials and methods
2.1. Chemicals and other materials
Anti-S-nitrosocysteine (S-NO-Cys) antibody, l-buthionine-sulphoxi-
mine (BSO), cyanamide, dithiothreitol (DTT), GSH-EE, GSNO,
NAD+, propionyl aldehyde, pyrazole, and sodium ascorbate were pur-
chased from Sigma (St. Louis, MO, USA). S-Nitroso-N-acetyl-D,L-
penicillamine (SNAP), and 3-morpholinosydnonimine Æ HCl (SIN-1)
were from Biomol (Plymouth Meeting, PA, USA). AminoLink Plus
immobilization kit from Pierce (Rockford, IL, USA) was used in pre-
paring the immunoaﬃnity columns. Polyclonal antibody to mitochon-
drial ALDH2 was prepared in rabbits as previously described [22].
This antibody was used to detect ALDH2 in washed mitochondriablished by Elsevier B.V. All rights reserved.
Fig. 1. Selective inhibition of ALDH2 activity after BSO exposure.
H4IIE-C3 cells, grown in large culture dishes (150 mm diameter), were
treated with 10 mM BSO up to 4 h, before cells were harvested.
Cytosolic and mitochondrial proteins (0.5 mg/assay) were used to
determine the activities of ALDH1 and ALDH2, respectively. Each
point represents the average ± S.D. of three determinations.
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ALDH1 and ALDH3 or other cytosolic ALDH isozymes by the
anti-ALDH2 antibody has not been tested.
2.2. Cell culture
H4IIE-C3 rat hepatoma cells, purchased from the American Type
Culture Collection (Manassa, VA, USA), were grown in Dulbeccos
modiﬁed Eagles medium supplemented with 5% fetal bovine serum,
10% horse serum, and antibiotics as described [7]. After treatment with
various agents for indicated times, the attached cells were washed twice
with cold PBS and harvested by centrifugation at 2500 · g for 5 min.
Mitochondrial pellets from the harvested cells were freshly prepared
by diﬀerential centrifugation [23], washed twice with cold PBS to
remove contaminating cytosolic proteins before being rapidly frozen,
and stored at 80 C until use. To prepare solubilized mitochondrial
proteins, frozen mitochondrial pellets were quickly thawed and incu-
bated in the mitochondria extraction buﬀer [23] with 1% CHAPS for
5 min. Protein concentration was determined using the BioRad protein
assay kit, as described [23,24].
2.3. Measurement of ALDH activities
ALDH2 activity was measured by increased production of NADH
at 340 nm by the method of Tank et al. [25]. The reaction mixture con-
tained: 60 mM Na-phosphate buﬀer (pH 8.5), 1 mM NAD+, 1 mM
EDTA and mitochondrial or cytosolic proteins (0.5 mg/assay). After
the reaction mixture was kept for 2 min at room temperature, the
enzyme reaction initiated by adding the substrate (10 lM propionyl
aldehyde). The absorbance change was monitored for 1 or 2 min to
calculate the rate of NADH production. Activities of cyosolic ALDH1
were determined by the same method, except that 10 mM pyrazole was
added to inhibit alcohol dehydrogenase activity [22,25] with two diﬀer-
ent concentrations of propionyl aldehyde (0.05 and 1.0 mM). Speciﬁc
activity of ALDH2 was calculated by using the molar extinction coef-
ﬁcient of reduced NAD(P) of 6.22 · 106 cm2 at 340 nm (Merck Index)
and 1 unit represents a reduction of 1 nmol NAD+/min/mg protein at
room temperature.
2.4. Determination of NO concentration
Total NO concentration was determined as nitrite by the method of
Green et al. [26] with slightlymodiﬁcations. Brieﬂy, sampleswere diluted
4-fold with deionized water and deproteinized by adding 1/20th volume
of 30% (w/v) ZnSO4. After centrifugation at 1500 · g for 5 min at room
temperature, the supernatant was transferred into the microcentrifuge
tubes containing the samevolumeofGriess reagent (1 g/L sulfanilamide,
25 g/L phosphoric acid, and 0.1 g/L N-1-naphthylethylenediamine).
After 10 min of color development at room temperature, the absorbance
at 540 nmwasmeasured to determine the nitrite content calculated from
the standard curve using sodium nitrite.2.5. Immunoaﬃnity puriﬁcation and immunoblot analysis
The IgG fraction of anti-ALDH2 antibody was covalently immobi-
lized onto AminoLink agarose beads by following the manufacturers
instruction. Immunoaﬃnity puriﬁcation of ALDH2 proteins from dif-
ferently treated samples was performed by the method [27]. The unpu-
riﬁed mitochondrial proteins and immunopuriﬁed ALDH2 proteins
were resolved on SDS–polyacrylamide gels and subjected to immuno-
blot analysis with the speciﬁc anti-ALDH2 antibody [22] or anti-S-
nitroso-Cys antibody and enhanced chemiluminescence detection.
The statistical analysis and other methods not described here were
the same as described [22–24].3. Results
3.1. Selective inhibition of ALDH2 in intact cells by BSO
To study the potential inhibition of ALDH2 in intact cells by
NO, we used H4IIEC3 cells as a model, since these cells contain
considerable amounts of catalytically active ALDH2 [6,7]. To
generate increased production of NO, we followed the method
of Corrales et al. [28] by using BSO through selective inhibition
of GSH synthesis. Under our conditions, the speciﬁc activity ofALDH2, which is the major mitochondrial ALDH enzyme
with a very low Km for acetaldehyde, in H4IIE-C3 cells was
1.8 units, which are comparable to those values reported earlier
[6]. Our results show that ALDH2 activity rapidly declined
after the BSO treatment. For instance, 30 min after BSO expo-
sure, approximately 50% of the ALDH2 activity was inhibited
while more than 70% activity was inhibited at 1 h. The inhibi-
tion persisted up to 4 h after BSO treatment (Fig. 1). In con-
trast, the speciﬁc activity (1.7 units) of cytosolic ALDH1 was
not inhibited by the BSO treatment, indicating a selective inhi-
bition of mitochondrial ALDH2 by BSO, possibly through
reduction of intracellular GSH and NO production [28]. These
results further suggest that the mitochondrial ALDH2 may
contain a local microenvironment with a higher aﬃnity to-
wards NO [17] than that of the cytosolic ALDH1 enzyme.
3.2. Reversible inhibition of ALDH2 by NO donors
To further evaluate the NO-mediated ALDH2 inhibition, we
studied whether ALDH2 activity can be inhibited by various
NO donors such as GSNO, SIN-1, and SNAP. Although the
relative levels of ALDH2 inhibition diﬀered slightly, all NO
donors tested in this study signiﬁcantly inhibited the ALDH2
activity, in a manner similar to that by cyanamide [1,7], a clas-
sical inhibitor of ALDH2 (Fig. 2A). In contrast, immunoblot
analysis showed similar amounts of ALDH2 proteins recog-
nized by the anti-ALDH2 antibody (Fig. 2B). These results
suggest that the ALDH2 inhibition by NO donors is likely
to be a result of NO-mediated modiﬁcation of ALDH2.
It is known that S-nitrosylated Cys residues are reversibly re-
duced to Cys especially in the presence of GSH, sodium ascor-
bate, or DTT [16,17,23,28]. To determine whether NO-
mediated modiﬁcation and the subsequent inhibition of
ALDH2 were reversible, we studied the eﬀects of GSH-EE, a
cell-permeable GSH provider, on NO-mediated ALDH2 inhi-
bition (Fig. 3A). Simultaneous addition of GSH-EE completely
blocked the BSO- or GSNO-mediated ALDH2 inhibition. Fur-
thermore, addition of 10 mM DTT and 5 mM sodium ascor-
bate signiﬁcantly restored the ALDH2 activity suppressed in
GSNO-treated cells (data not shown). All these results indicate
that reversible regulation of ALDH2 in intact H4IIE-C3 cells
could occur by the cellular levels of NO and GSH.
3.3. Increased nitrite concentrations by NO donor compounds
To verify whether nitrite concentrations were increased
under our conditions, we further measured the levels of nitrite
Fig. 2. Inactivation of ALDH2 by various compounds including NO donors. (A) H4IIE-C3 cells were exposed to various agents: 1 mM cyanamide,
10 mM BSO, 0.5 mMGSNO, 1.0 mM SNAP, or 1.0 mM SIN-1 for 4 h, before cells were harvested. Mitochondrial proteins (0.5 mg/assay) were used
to measure the ALDH2 activity. ALDH2 activity in each sample is compared to that of the untreated control. Each point represents the
average ± S.D. of three determinations. * and **Signiﬁcant diﬀerence (*P < 0.005 and **P < 0.01) from the control sample. (B) Equal amounts of
mitochondrial proteins (20 lg/well) from the same set of samples were separated on 12% SDS–PAGE and subjected to immunoblot analysis using the
anti-ALDH2 antibody. Migration of molecular weight marker proteins is shown in the left.
Fig. 3. Complete blockade of BSO- or GSNO-mediated inhibition of
ALDH2 activity and increased nitrite concentrations by GSH-EE.
H4IIE-C3 cells were exposed to the following agents: either 10 mM
BSO or 0.5 mM GSNO in the absence and presence of 5 mM GSH-EE
for 4 h, before cells were harvested. (A) Mitochondrial proteins
(0.5 mg/assay) were used to measure the activities of ALDH2. ALDH2
activity in each sample is compared to that of untreated control. Each
point represents the average ± S.D. of three determinations. (B)
Mitochondrial proteins (0.4 mg/assay) were used to determine the
nitrite concentrations. Each point represents the average ± S.D. of
three determinations. *Signiﬁcant diﬀerence (P < 0.005) from the
control sample.
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the nitrite concentrations (Fig. 3B), although a higher nitrite
concentration was observed with GSNO than with BSO, which
reduces the intracellular GSH content and thus indirectly
aﬀects the nitrite level [28]. GSH-EE also completely blocked
the increased nitrite concentrations caused by BSO or GSNO.
These results suggest that the increased nitrite concentrations
are likely to inhibit the ALDH2 activity through the modiﬁca-
tion of its Cys residue(s).
3.4. Evidence for NO-mediated S-nitrosylation of Cys residue(s)
of ALDH2
To directly demonstrate the NO-mediated S-nitrosylation of
ALDH2, the mitochondrial ALDH2 proteins in untreated
control and GSNO-treated cells in the absence and presence
of GSH-EE, respectively, were puriﬁed by immunoaﬃnity col-
umns using the IgG fraction of anti-ALDH2 antibody. Similar
amounts of ALDH2 protein (54 kDa) were detected by immu-
noblot analysis for the immunopuriﬁed ALDH2 proteins from
diﬀerent treatments (Fig. 4, top panel). Immunoblot analysis
with the anti-S-NO-Cys antibody showed that one immunore-
active band (54 kDa) was recognized for the immunopuriﬁed
ALDH2 only from the GSNO-treated cells (Fig. 4, bottom pa-
nel, lane 3). However, the immunoreactive S-NO-Cys band
disappeared (lane 2) when GSH-EE was added, consistent with
the restoration of ALDH2 activity (Fig. 3A). These results
provide direct evidence for NO-mediated S-nitrosylation of
Cys residue(s) of ALDH2, causing the reversible inhibition
of ALDH2 activity.4. Discussion
Despite many reports on the inhibition of ALDH2 following
exposure to toxic chemicals [9–11] and pathological conditions
Fig. 4. Immunoblot analysis for immunopuriﬁed ALDH2 proteins.
H4IIE-C3 cells were treated with diﬀerent agents as indicated.
Mitochondrial ALDH2 proteins from the diﬀerently treated cells were
puriﬁed by immunoaﬃnity chromatography and subjected to immu-
noblot analysis using the anti-ALDH2 antibody (top) or the anti-S-
NO-Cys antibody (bottom).
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stood. We hypothesized that the active site Cys302 [19] must be
modiﬁed and thus inhibited by increased ROS/RNS and/or
peroxynitrite produced under stressful conditions [9–15] due
to decreased ALDH2 activities. It is known that Cys residues
can undergo the following modiﬁcations: oxidation to disul-
ﬁdes [21,29], sulfenic acid [30], sulﬁnic acid and sulfonic acid
[31], S-glutathionylation [32], S-nitrosylation [16,17], ADP-
ribosylation [20], etc. In addition, Cys residues in ALDH2
were shown to be covalently modiﬁed with the reactive metab-
olites of acetaminophen [10] or disulﬁram [33], thus becoming
inactivated. Therefore, it is possible that the active site Cys in
the ALDH2 protein underwent one of these modiﬁcations and
became inactivated after cells were exposed to BSO or GSNO.
Our current results show that ALDH2 in intact cells is modi-
ﬁed by NO-dependent S-nitrosylation based on the following
facts: the inhibition of ALDH2 activity by BSO and GSNO;
the increased nitrite concentrations after BSO and GSNO
treatments; the recognition of the immunopuriﬁed ALDH2
with the anti-S-NO-Cys antibody; and the complete blockade
of BSO- or GSNO-mediated ALDH2 inhibition, increased ni-
trite concentrations, and S-nitrosylation in the presence of
GSH-EE. To our knowledge, our results represent the ﬁrst re-
port about the inhibition of ALDH2 in intact cells via NO-
mediated S-nitrosylation.
DeMaster et al. [21] reported that Cys residues of the puri-
ﬁed ALDH2 can be oxidized to intra-subunit disulﬁdes rather
than S-nitrosylation in the presence of NO donors while the
oxidized enzyme was not reduced by the addition of GSH.
Cys residues of the puriﬁed ALDH2 can also be modiﬁed by
ADP-ribosylation in an NO-independent manner [20]. How-
ever, these kinds of modiﬁcations of ALDH2 in intact cells
and potential S-nitrosylation of ALDH2 have not been stud-
ied, despite the well-characterized S-nitrosylation of Cys resi-
dues in many other proteins [16,17,28]. Our current results
showed that ALDH2 in intact cells is S-nitrosylated by NOwith the concurrent inhibition of its activity. We do not know
the reason why we observed the GSH-mediated blockade of S-
nitrosylation and inhibition of ALDH2 caused by NO donors,
whereas DeMaster et al. [21] did not. The diﬀerence could sim-
ply result from the diﬀerent status of Cys residue(s) of
ALDH2: S-nitrosylation versus disulﬁde bond formation.
These results warrant precaution in interpreting the data with
the puriﬁed enzyme.
Although it is theoretically possible to identify the S-nitrosy-
lated cysteine residues, we were unsuccessful in this eﬀort be-
cause of small amounts of the cultured H4IIE-C3 cells.
Despite the failure to identify the modiﬁed Cys residue(s) by
protein sequencing analysis, we believe that Cys162 may not
be the S-nitrosylated Cys since mutation of this residue
decreases the ALDH2 stability [19] and we did not observe
reduced amounts of ALDH2 after GSNO treatment
(Fig. 2B). It was also shown that Cys49 is not involved in the
catalytic activity [19]. Subsequently, S-nitrosylation of Cys49
is not likely to change the ALDH2 activity after GSNO treat-
ment. Because of the reduced ALDH2 activity after treatment
with NO donors (Fig. 2), we conclude that Cys302 of ALDH2
must be the S-nitrosylated cysteine residue. Our preliminary
results also showed that ALDH2 activity was inhibited and
S-nitrosylated (detected with the anti-S-NO-Cys antibody
after immunopuriﬁcation) in alcohol-exposed rats. To directly
demonstrate S-nitrosylation of the active site Cys302, the
immunopuriﬁed ALDH2 from alcohol-treated rat livers is
being analyzed by proteomics approaches.
Under pathological conditions or after exposure to toxic
chemicals, increased ROS/RNS production leads to elevated
lipid peroxidation with increased levels of lipid aldehydes [4].
Reactive acetaldehyde and lipid aldehydes such as HNE and
MDA are usually metabolized by ALDH2, alcohol dehydroge-
nase, and glutathione S-transferase [4,5]. However, ALDH2
can be inhibited by various potentially toxic chemicals such
as CCl4 [9] and acetaminophen [10]. Although the molecular
mechanism of the ALDH2 inhibition by these agents has not
been elucidated further, it is likely that these chemicals can
inhibit the ALDH2 activity by S-nitrosylation of Cys resi-
due(s), as shown in the current study, because these chemicals
are also known to activate the inducible NO synthase and/or
increase peroxynitrite production [34]. Inhibition of ALDH2
subsequently leads to marked elevations of reactive aldehydes
including HNE and MDA. These conditions are likely to in-
crease susceptibility toward irreversible cell damage, unless
these conditions are properly treated by suitable measures.
In fact, markedly elevated levels of acetaldehyde (as protein
adducts) [22,35] and lipid aldehydes such as HNE are fre-
quently observed in alcoholic hepatitis and other chronic dis-
ease states [13,35,36]. These data may suggest an important
role of ALDH2 in cellular protection against potential damage
by reactive aldehydes as demonstrated [37]. In addition, poten-
tial inhibition of ALDH2 by various chemicals [9–11] or path-
ological conditions [12–15] may reduce the eﬃcacy of
nitroglycerins used in treating acute angina and congestive
heart failure, since ALDH2 plays a critical role in bioactiva-
tion of nitroglycerins [38,39]. Alternatively inhibition of
ALDH2 may cause tolerance toward nitroglycerin-mediated
relaxation of blood vessels [40]. Based on these views, it would
be of interest to ﬁnd out whether S-nitrosylation and subse-
quent inhibition of ALDH2 activity can be observed in animal
models of stressful or pathological conditions.
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